Yaser Abolhasani

Yaser Abolhasani

Auto-generated profile, based on publicly available information

Yaser Abolhasani

Department of Operating Room Technology, School of Paramedical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in Iranian South Medical Journal
Verified
Journal Article
Open access
PDF file
YAYaser Abolhosni
Yaser Abolhosni
MAMohsen Absalan
Mohsen Absalan
MZMohammadali Zakeri
Mohammadali Zakeri
SBSohila Bakhtiari
Sohila Bakhtiari
Background: Skin preparation in the operating room is important to prevent infection after open fracture surgery. The present study was conducted with the aim of investigating the effect of the simultaneous use of betadine and vancomycin powder for the preparation of damaged skin in preventing wound infection in open fractures ...

28 March 2026 in Journal of Nephropathology
Verified
Journal Article
Open access
PDF file
MRMohammad Rostamzadeh
Mohammad Rostamzadeh
YAYaser Abolhasani
Yaser Abolhasani
AHAmir Heidari
Amir Heidari
ARAbdolmohammad Ranjbar
Abdolmohammad Ranjbar
AEAli Emadzadeh
Ali Emadzadeh
RFReza Faramarzzadeh
Reza Faramarzzadeh
Introduction: Chronic inflammation plays a significant role in cardiovascular disease (CVD)–related mortality among patients with chronic kidney disease (CKD). The neutrophil‑to‑albumin percentage ratio (NPAR) has emerged as an indicator of an individual’s inflammatory status. This study aimed to investigate the association between elevated NPAR and the risk of CVD mortality in patients with CKD. Materials and Methods: The study was conducted in accordance with the PRISMA reporting guidelines. Comprehensive searches were performed across the Cochrane Library, Scopus, Web of Science, Embase, and PubMed databases, as well as the Google Scholar search engine, up to 30 January 2026. All statistical analyses were carried out using STATA version 14. Results: Compared with lower NPAR values, elevated NPAR was associated with a higher risk of cardiovascular mortality (OR = 1.54; 95% CI: 1.33–1.78) and all‑cause mortality (OR = 1.62; 95% CI: 1.40–1.89) in patients with CKD. In addition, higher NPAR increased the risk of CVD‑related death among patients undergoing hemodialysis (OR = 1.66; 95% CI: 1.29–2.15) and peritoneal dialysis (OR = 1.56; 95% CI: 1.25–1.94). Furthermore, the third quartile of NPAR (OR = 1.44; 95% CI: 1.16–1.78), the fourth quartile (OR = 1.92; 95% CI: 1.61–2.30), the second tertile (OR = 1.38; 95% CI: 1.07–1.80), and the third tertile (OR = 1.97; 95% CI: 1.61–2.41) were all associated with increased CVD mortality compared with the lowest category. Elevated NPAR also increased the risk of CVD‑related mortality in both men (OR = 1.23; 95% CI: 1.04–1.45) and women (OR = 1.16; 95% CI: 1.08–1.24) with CKD. Conclusion: Higher NPAR levels were associated with an increased likelihood of cardiovascular and all‑cause mortality among individuals with CKD. As NPAR values rose, the risk of CVD‑related death increased correspondingly when compared with lower levels. In addition, cardiovascular mortality risk was greater in men than in women, and higher among patients receiving hemodialysis than those undergoing peritoneal dialysis. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420261304086) and Research Registry (UIN: reviewregistry2082) websites.